Thorac Cardiovasc Surg 2010; 58(8): 459-462
DOI: 10.1055/s-0030-1250005
Original Cardiovascular

© Georg Thieme Verlag KG Stuttgart · New York

Peripheral versus Central Cannulation for Extracorporeal Membrane Oxygenation: A Comparison of Limb Ischemia and Transfusion Requirements

H. D. Kanji1 , C. J. Schulze1 , A. Oreopoulos2 , 3 , E. J. Lehr3 , W. Wang1 , R. M. MacArthur1
  • 1Division of Cardiac Surgery, University of Alberta, Edmonton, Canada
  • 2Department of Public Health, University of Alberta, Edmonton, Canada
  • 3Division of Cardiac Surgery, University of Maryland, Baltimore, Maryland, United States
Further Information

Publication History

received March 19, 2010

Publication Date:
25 November 2010 (online)

Abstract

Background: Extracorporeal membrane oxygenation (ECMO) can be instituted centrally, through the right atrium and ascending aorta, or peripherally, most commonly using the femoral artery and vein. We sought to investigate the impact of the mode of cannulation on the incidence of limb ischemia, perfusion and overall morbidity. Methods: A retrospective analysis of 50 consecutive patients over 5 years who underwent ECMO by central or peripheral cannulation was performed. Results: There was no difference in the incidence of limb ischemia and end-organ perfusion when peripheral and central cannulation cohorts were compared. Central cannulation was associated with a higher incidence of bleeding from the cannulation site (64 % vs. 18 %, p = 0.002), blood product utilization and reoperation (66 % vs. 14 %, p < 0.0001). 30-day mortality was similar in both cohorts (46 % peripheral, 50 % central, p = 0.8). Conclusion: Our results suggest that there is comparable tissue perfusion and limb ischemia with both cannulation techniques. Central cannulation is associated with a higher incidence of bleeding, higher transfusion rates, a greater need for reoperation and greater resource utilization. Therefore, peripheral cannulation is safe and may be advantageous in certain clinical scenarios.

References

  • 1 Lim M W. The history of extracorporeal oxygenators.  Anaesthesia. 2006;  61 984-995
  • 2 Hewitt R L, Creech Jr O. History of the pump oxygenator.  Arch Surg. 1966;  93 680-696
  • 3 Magliato K E, Kleisli T, Soukiasian H J, Tabrizi R, Coleman B, Hickey A, Czer L S, Blanche C, Cheng W, Fontana G P, Kass R M, Raissi S S, Trento A. Biventricular support in patients with profound cardiogenic shock: a single center experience.  ASAIO J. 2003;  49 475-479
  • 4 Bartlett R H, Kolobow T, Cooper J D, Richardson P D. Extracorporeal gas exchange, lung transplantation, and the artificial lung.  Trans Am Soc Artif Intern Organs. 1984;  30 679-681
  • 5 Doll N, Kiaii B, Borger M, Bucerius J, Kramer K, Schmitt D V, Walther T, Mohr F W. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock.  Ann Thorac Surg. 2004;  77 151-157
  • 6 Lazar H L, Treanor P, Yang X M, Rivers S, Bernard S, Shemin R J. Enhanced recovery of ischemic myocardium by combining percutaneous bypass with intraaortic balloon pump support.  Ann Thorac Surg. 1994;  57 663-668
  • 7 Oliver W C. Anticoagulation and coagulation management for ECMO.  Semin Cardiothorac Vasc Anesth. 2009;  13 154-175
  • 8 Baird C W, Zurakowski D, Robinson B, Gandhi S, Burdis-Koch L, Tamblyn J, Munoz R, Fortich K, Pigula F A. Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival.  Ann Thorac Surg. 2007;  83 912-920
  • 9 Vanzetto G, Akret C, Bach V, Barone G, Durand M, Chavanon O, Hacini R, Bouvaist H, Machecourt J, Blin D. [Percutaneous extracorporeal life support in acute severe hemodynamic collapses: single center experience in 100 consecutive patients].  Can J Cardiol. 2009;  25 e179-e186
  • 10 Muehrcke D D, McCarthy P M, Stewart R W, Foster R C, Ogella D A, Borsh J A, Cosgrove D M. Extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock.  Ann Thorac Surg. 1996;  61 684-691
  • 11 Murphy G J, Reeves B C, Rogers C A, Rizvi S I, Culliford L, Angelini G D. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery.  Circulation. 2007;  116 2544-2552
  • 12 Koch C G, Li L, Sessler D I, Figueroa P, Hoeltge G A, Mihaljevic T, Blackstone E H. Duration of red-cell storage and complications after cardiac surgery.  N Engl J Med. 2008;  358 1229-1239
  • 13 Wasowska B A, Lee C Y, Halushka M K, Baldwin 3rd W M. New concepts of complement in allorecognition and graft rejection.  Cell Immunol. 2007;  248 18-30
  • 14 Zimring J C, Hair G A, Deshpande S S, Horan J T. Immunization to minor histocompatibility antigens on transfused RBCs through crosspriming into recipient MHC class I pathways.  Blood. 2006;  107 187-189
  • 15 Shander A, Hofmann A, Gombotz H, Theusinger O M, Spahn D R. Estimating the cost of blood: past, present, and future directions.  Best Pract Res Clin Anaesthesiol. 2007;  21 271-289
  • 16 Kanavos P, Yfantopoulos J, Vandoros C, Politis C. The economics of blood: gift of life or a commodity?.  Int J Technol Assess Health Care. 2006;  22 338-343
  • 17 Cremieux P Y, Barrett B, Anderson K, Slavin M B. Cost of outpatient blood transfusion in cancer patients.  J Clin Oncol. 2000;  18 2755-2761
  • 18 Madershahian N, Nagib R, Wippermann J, Strauch J, Wahlers T. A simple technique of distal limb perfusion during prolonged femoro-femoral cannulation.  J Card Surg. 2006;  21 168-169
  • 19 Huang S C, Yu H Y, Ko W J, Chen Y S. Pressure criterion for placement of distal perfusion catheter to prevent limb ischemia during adult extracorporeal life support.  J Thorac Cardiovasc Surg. 2004;  128 776-777

Dr. Hussein D. Kanji, MD, MSc, MPH

Division of Cardiac Surgery
Mazankowksi Alberta Heart Institute
University of Alberta

8440-112 St., Rm 1G1.50

Edmonton, AB, T6G 2B7

Canada

Phone: +1 78 05 04 82 28

Fax: +1 78 04 07 21 84

Email: hdkanji@gmail.com

    >